{"id":"https://openalex.org/W2598455141","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.9543","title":"High-throughput RNAi screening identifies sensitizing targets to improve doxorubicin chemotherapy","display_name":"High-throughput RNAi screening identifies sensitizing targets to improve doxorubicin chemotherapy","publication_year":2004,"publication_date":"2004-07-15","ids":{"openalex":"https://openalex.org/W2598455141","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.9543","mag":"2598455141"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2004.22.14_suppl.9543","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.9543","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.22.14_suppl.9543","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012734710","display_name":"David O. Azorsa","orcid":"https://orcid.org/0000-0001-7747-8457","observed_orcids":["https://orcid.org/0000-0001-7747-8457"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. O. Azorsa","raw_affiliation_strings":["Translational Genomics Research Institute, Gaithersburg, MD; National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Genomics Research Institute, Gaithersburg, MD; National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064611417","display_name":"Jeffrey Kiefer","orcid":"https://orcid.org/0000-0002-1238-3120","observed_orcids":["https://orcid.org/0000-0002-1238-3120"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. A. Kiefer","raw_affiliation_strings":["Translational Genomics Research Institute, Gaithersburg, MD; National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Genomics Research Institute, Gaithersburg, MD; National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":null,"display_name":"M. L. White","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. L. White","raw_affiliation_strings":["Translational Genomics Research Institute, Gaithersburg, MD; National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Genomics Research Institute, Gaithersburg, MD; National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033135393","display_name":"P. Rojanapraparn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. Rojanapraparn","raw_affiliation_strings":["Translational Genomics Research Institute, Gaithersburg, MD; National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Genomics Research Institute, Gaithersburg, MD; National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052362487","display_name":"Natasha J. Caplen","orcid":"https://orcid.org/0000-0002-0001-9460","observed_orcids":["https://orcid.org/0000-0002-0001-9460"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"N. J. Caplen","raw_affiliation_strings":["Translational Genomics Research Institute, Gaithersburg, MD; National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Genomics Research Institute, Gaithersburg, MD; National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050670008","display_name":"Olli Kallioniemi","orcid":"https://orcid.org/0000-0002-3231-0332","observed_orcids":["https://orcid.org/0000-0002-3231-0332"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"O. Kallioniemi","raw_affiliation_strings":["Translational Genomics Research Institute, Gaithersburg, MD; National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Genomics Research Institute, Gaithersburg, MD; National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5054693021","display_name":"Spyro Mousses","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Mousses","raw_affiliation_strings":["Translational Genomics Research Institute, Gaithersburg, MD; National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Genomics Research Institute, Gaithersburg, MD; National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"22","issue":"14_suppl","first_page":"9543","last_page":"9543"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.6894999742507935,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.6894999742507935,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.18569999933242798,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.013399999588727951,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.9950000047683716},{"id":"https://openalex.org/keywords/chemosensitization","display_name":"chemosensitization","score":0.8889999985694885},{"id":"https://openalex.org/keywords/rnai-screening","display_name":"RNAi screening","score":0.7160000205039978},{"id":"https://openalex.org/keywords/sirna","display_name":"siRNA","score":0.5879999995231628},{"id":"https://openalex.org/keywords/hela-cells","display_name":"HeLa cells","score":0.781000018119812},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.5960000157356262},{"id":"https://openalex.org/keywords/chemogenomics","display_name":"chemogenomics","score":0.6859999895095825},{"id":"https://openalex.org/keywords/topoisomerase-ii-inhibition","display_name":"topoisomerase II inhibition","score":0.7519999742507935},{"id":"https://openalex.org/keywords/anthracycline-resistance","display_name":"anthracycline resistance","score":0.6899999976158142},{"id":"https://openalex.org/keywords/gene-silencing","display_name":"gene silencing","score":0.6779999732971191},{"id":"https://openalex.org/keywords/cancer-therapy-targets","display_name":"cancer therapy targets","score":0.46299999952316284}],"concepts":[{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.841093897819519},{"id":"https://openalex.org/C166703698","wikidata":"https://www.wikidata.org/wiki/Q201993","display_name":"RNA interference","level":4,"score":0.8329265713691711},{"id":"https://openalex.org/C173396325","wikidata":"https://www.wikidata.org/wiki/Q1501275","display_name":"Gene knockdown","level":3,"score":0.7888962030410767},{"id":"https://openalex.org/C119056186","wikidata":"https://www.wikidata.org/wiki/Q1431332","display_name":"Gene silencing","level":3,"score":0.7606381177902222},{"id":"https://openalex.org/C22615655","wikidata":"https://www.wikidata.org/wiki/Q203221","display_name":"Small interfering RNA","level":4,"score":0.7563426494598389},{"id":"https://openalex.org/C54009773","wikidata":"https://www.wikidata.org/wiki/Q1429031","display_name":"Transfection","level":3,"score":0.5687945485115051},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4998586177825928},{"id":"https://openalex.org/C2777366897","wikidata":"https://www.wikidata.org/wiki/Q847482","display_name":"HeLa","level":3,"score":0.43170538544654846},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.4237039089202881},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4090762734413147},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.38900354504585266},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.38814231753349304},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.345974862575531},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3403382897377014},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.2779659628868103},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.2698690891265869},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.22390908002853394},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09774002432823181},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.08686387538909912}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1200/jco.2004.22.14_suppl.9543","doi":"https://doi.org/10.1200/jco.2004.22.14_suppl.9543","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.22.14_suppl.9543","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"doi:10.1200/jco.2004.22.90140.9543","doi":"https://doi.org/10.1200/jco.2004.22.90140.9543","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2004.22.90140.9543","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4221099978","https://openalex.org/W2387166625","https://openalex.org/W2185878867","https://openalex.org/W3097425165","https://openalex.org/W2366097957","https://openalex.org/W2161279196","https://openalex.org/W2071786426","https://openalex.org/W2388744767","https://openalex.org/W2097214456","https://openalex.org/W2964583184"],"abstract_inverted_index":{"9543":[0],"Treatment":[1],"of":[2,8,32,62,68,96,114,130,142,153,179,211,214,223,225,254,290,301],"cancer":[3,291],"often":[4],"involves":[5],"the":[6,46,60,79,93,151,221,226,299],"use":[7],"chemotherapeutic":[9,316],"agents":[10],"that":[11,21,104,220,263,279],"preferentially":[12],"target":[13],"tumor":[14],"cells.":[15],"Doxorubicin":[16],"is":[17,99],"an":[18,23,208],"anthracycline":[19],"antibiotic":[20],"induces":[22],"anticancer":[24,94],"effect":[25],"through":[26],"intercalation":[27],"into":[28,123],"DNA,":[29],"and":[30,43,161,184,246,274],"inhibition":[31],"topoisomerase":[33],"II.":[34],"However,":[35],"not":[36,197],"all":[37],"patients":[38],"benefit":[39],"from":[40],"doxorubicin":[41,63,163,180,255],"therapy":[42],"heterogeneity":[44],"in":[45,64,85,205,265,268],"response":[47],"to":[48,58,77,81,92,125,149,232,239,293,311,315,322],"this":[49],"agent":[50],"has":[51],"limited":[52],"its":[53],"clinical":[54],"efficacy.":[55],"In":[56],"order":[57],"improve":[59],"efficiency":[61],"a":[65,83,100,140,175,251,258,266,306],"greater":[66],"number":[67],"patients,":[69],"we":[70],"used":[71],"RNA":[72,112],"interference":[73],"(RNAi)":[74],"knockdown":[75],"experiments":[76],"determine":[78],"extent":[80],"which":[82],"change":[84],"gene":[86,131,154],"expression":[87],"can":[88,105],"increase":[89,260],"cellular":[90],"sensitivity":[91,231],"effects":[95,152,215],"doxorubicin.":[97,212,233,294],"RNAi":[98,137,304],"naturally":[101],"occurring":[102],"mechanism":[103],"be":[106],"experimentally":[107],"exploited":[108],"by":[109,243,271],"introducing":[110],"double-stranded":[111],"molecules":[113],"\u223c21":[115],"base":[116],"pairs":[117],"termed":[118],"short":[119],"interfering":[120],"RNAs":[121],"(siRNAs)":[122],"cells":[124,170,292],"achieve":[126],"sequence":[127],"specific":[128],"silence":[129],"expression.":[132],"We":[133],"have":[134],"applied":[135],"high-throughput":[136,303],"analysis":[138],"using":[139,302],"library":[141],"83":[143],"siRNAs":[144],"against":[145],"40":[146,227],"cancer-associated":[147],"genes":[148,228,281],"assess":[150],"silencing":[155,222],"on":[156,216],"HeLa":[157],"cell":[158,185,200,217,241,269],"survival":[159,201,218],"with":[160,173,207],"without":[162],"treatment.":[164],"Eighteen":[165],"hours":[166,190],"after":[167,191],"siRNA":[168,192,195,237],"transfection,":[169],"were":[171],"treated":[172],"either":[174,202],"low":[176,252],"(ineffective)":[177],"dose":[178,210,253],"or":[181,204],"vehicle":[182],"control":[183],"viability":[186,242,270],"was":[187,256,261],"measured":[188],"72":[189],"transfection.":[193],"Control":[194],"did":[196],"significantly":[198,229],"affect":[199],"alone,":[203,248],"combination":[206],"ineffective":[209],"Analysis":[213],"revealed":[219],"three":[224,235],"increased":[230],"The":[234],"effective":[236],"lead":[238],"decreased":[240],"14,":[244],"6":[245],"25%":[247],"but":[249],"when":[250],"added":[257],"synergistic":[259],"observed":[262],"resulted":[264],"decrease":[267],"73,":[272],"81":[273],"93%.":[275],"These":[276],"results":[277],"indicate":[278],"these":[280,296],"could":[282],"serve":[283],"as":[284,305],"putative":[285],"therapeutic":[286],"targets":[287,314],"for":[288,308],"sensitization":[289],"Furthermore,":[295],"findings":[297],"demonstrate":[298],"effectiveness":[300],"tool":[307],"functional":[309],"chemogenomics":[310],"identify":[312],"sensitizing":[313],"agents.":[317],"No":[318],"significant":[319],"financial":[320],"relationships":[321],"disclose.":[323]},"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2017-04-07T00:00:00"}